257854 Injection drug users on HIV-prevention service delivery: Lessons for building effective syringe access programs

Tuesday, October 30, 2012 : 8:45 AM - 9:00 AM

Katie Burk, MPH , CBA Department, Harm Reduction Coalition, Oakland, CA
Narelle Ellendon, RN , CBA Department, Harm Reduction Coalition, New York, NY
Background Injection Drug Users (IDUs) are at risk for acquiring HIV through shared injection equipment and sexual practices. Extensive research has demonstrated syringe access programs (SAPs) to be an effective HIV-prevention intervention for this population. The effectiveness of services is often measured by numbers of syringes distributed and collected, but participant satisfaction with services is rarely measured. This project seeks to assess IDUs' evaluation of the effectiveness of the SAPs and other HIV-prevention programs utilized. Methods HRC staff conducted eleven focus groups with Injection Drug Users in six states (NJ, HI, CO, NV, ME, AZ). In each location, an HIV-Prevention service provider recruited IDUs by offering incentives such as gift cards. Participants answered open-ended questions about service delivery, injection equipment provided, experiences with law enforcement, pharmacy access, hepatitis C knowledge, and consumer involvement. HRC staff recorded and transcribed sessions, and qualitatively analyzed them using grounded theory. Results Fifty-seven total IDUs participated in eleven focus groups. Focus group participants expressed appreciation for programs and a willingness to access ancillary SAP services such as treatment referrals, vaccination and testing, and medical services. Participants often reported the need for more HCV education and negative experiences with law enforcement and/or pharmacists, and described the risks associated with not receiving adequate amounts of injection equipment in some locations. Conclusions IDUs' favorable descriptions of SAPs underscore the success of programs not only in delivering effective preventative services, but also in utilizing a compassionate, client-centered model of service. Iterative assessment of programs via consumer feedback is recommended.

Learning Areas:
Administer health education strategies, interventions and programs
Administration, management, leadership
Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Program planning
Protection of the public in relation to communicable diseases including prevention or control

Learning Objectives:
Discuss three barriers to accessing syringe access programs that are commonly experienced by injection drug users. Identify three potential ways of involving injection drug users in the design and delivery of syringe access services. Explain why a distribution model for syringe access programs is better able to reduce injection-related risk behaviors than a one-for-one model.

Keywords: Injecting Drug Use, Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the principle researcher on this project and have an MPH in Community Public Health Practice. I have ten years of experience working with Injection Drug Users in an HIV-Prevention and care capacity.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4043.0: HIV and Injection Drug Use